- Chairs’ Introduction
- Scientific Committee
- Scientific Programme 2017
- General Information
- Contact Us
- Associated Links
- Abstracts and Posters
Welcome to the HIV & Hepatitis in the Americas congress 2017.
The aim of this meeting is to bring together practicing ID physicians and clinicians together with physicians dealing with Hepatitis patients. The congress provides an opportunity to share day-to-day issues and challenges in the treatment of patients, bringing together public health, clinical and basic science agendas in specific sessions highlighting key issues. We are delighted to be working in collaboration with the International AIDS Society and PAHO for the 2017 congress whose involvement you will see noted in the scientific programme.
June 2013 saw the first HIV Drug Therapy in the Americas Congress take place in São Paulo, Brazil. This inaugural meeting brought together attendees from 17 countries from across the Central, South and Latin America region and beyond. With a focus on therapeutic research and the treatment of HIV/AIDS, building on the ‘HIV Glasgow’ heritage the congress tackled known issues and addressed these using a mix of session types from plenary presentations to case-based discussion. The incorporation of discussion within sessions proved popular and ensured that the key issues in the region were addressed. Since then the meeting has been held annually in Brazil or Mexico. The Committee have retained the balance of invited presentations, case- and panel-based discussions and broader topics important across the region drawing in local perspectives, building the geographic reach and working with key organisations to further reinforcing the value and interest in the meeting. There has been a sustained increase in the quality of the programme and increased engagement among key players in Latin America. The inclusion of the Hepatitis agenda within this three-day programme was considered an important development, and has been welcomed by attendees.
The focus of the programme is tailored to Latin American treatment issues, the involvement of internationally renowned speakers with an understanding of the region is imperative. It is their perspective and authoritative status that lends key credibility to the invited programme. By bringing a faculty of leaders from both the international and regional fields delegates who habitually may not have the opportunity to travel to international meetings can take advantage of the broad experiences and knowledge-base in their home territories. Collaborations with institutions and organisations with a working involvement in the region is encouraged. Full flexibility for speakers and participants to use English, Spanish or Portuguese when presenting/asking questions is considered key.
With the intention of continuing to develop the enthusiasm and momentum already gained, we invite you to attend the 2017 iteration of HIV & Hepatitis in the Americas Congress which will take place in Rio de Janeiro, Brazil between 6 and 8 April 2017.